ArticleFrontiers in medicine2023

Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.

Tatsuhiko Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.